EP2265259A1 — Rapidly disintegrating oral compositions of tramadol
Assigned to Zydus Lifesciences Ltd · Expires 2010-12-29 · 15y expired
What this patent protects
The present invention relates to a stable taste masked orally disintegrating pharmaceutical composition of tramadol comprising of 3 % to 30 % w/w of tramadol, 2 % to 30 %w/w of an ion exchange resin, 0.01 to about 2 %w/w of binder and pharmaceutically acceptable excipients to equ…
USPTO Abstract
The present invention relates to a stable taste masked orally disintegrating pharmaceutical composition of tramadol comprising of 3 % to 30 % w/w of tramadol, 2 % to 30 %w/w of an ion exchange resin, 0.01 to about 2 %w/w of binder and pharmaceutically acceptable excipients to equal 100 %w/w, wherein the binder used is gelatin. :
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.